RenovoRx (RNXT) Other Operating Expenses (2026)
RenovoRx's (RNXT) quarterly Other Operating Expenses came in at -$2000.0 in Q2 2026.
Powered by 
Analysis
RenovoRx (RNXT) Other Operating Expenses (2026) Analysis & Trends
RenovoRx has disclosed Other Operating Expenses across 1 years of filings, most recently posting -$2000.0 for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn |
| 10 | RenovoRx | 84.43 Mn | 84.43 Mn | 766,000.00 |